Prognostic Implication of Framingham Risk Score As a Comorbidity Measure on Treatment Outcomes Following First-Line Tyrosine Kinase Inhibitor in Newly Diagnosed CML PatientsMay Chiu, Dennis Dong Hwan Kim, Jaeyoon Kim et al.|Blood|2024Cited by 0